Gaia Grow Corp. (CNSX:GAIA) acquired Gaia Bio-Pharmaceuticals Inc., on March 22, 2019. Gaia Grow Corp. (CNSX:GAIA) completed the acquisition of Gaia Bio-Pharmaceuticals Inc., on March 22, 2019. Pursuant to the terms of the acquisition, the consideration includes (a) CAD 200,000, paid in a series of tranches, as a non-refundable deposit to the shareholders of Gaia Bio (CAD 76,000 paid and CAD 124,000 has been recorded in due to related party). The amount due to related party is non-interest bearing and repayable upon demand; (b) the issuance of 7% of the issued and outstanding common shares of Gaia Grow Corp. (estimated to be an aggregate of 8,400,000 common shares of Gaia Grow Corp.) (pending); (c) a conditional payment of CAD 1,600,000 in cash or equivalent in common shares of Gaia Grow Corp., in the event that the common shares of Gaia Grow Corp., are valued less than CAD 2,000,000 at any time during the 60-day period after Gaia Grow Corp., is in receipt of a license to cultivate from Health Canada; (d) Gaia Grow Corp., will assume a business loan in the amount of CAD 10,625 (currently in the amount of CAD 6,123); and (e) Gaia Grow Corp., will assume Gaia Bio’s commitment pursuant to an Offer to Purchase Agreement (“Offer to Purchase”) whereby Gaia Bio agreed to purchase a plot of land (the “Property”) located in Lamont County, Alberta for the purpose of growing hemp. The purchase price, as last amended, is CAD 190,000 and 5% of the total number of common shares of Gaia Bio, subject to the condition that the number of shares may change depending on whether more shares are issued. Closing of the transaction is to be 30 days after Gaia Bio receives Health Canada’s pre-approval “letter-to-build” (“LTB”), which has not yet been obtained. Further, Gaia Grow Corp., will pay CAD 1,000/month in purchase extension fees until closing of the Offer to Purchase. Consequently, Gaia Bio became a wholly-owned subsidiary of Gaia Grow Corp.